1/102
A comprehensive set of vocabulary flashcards covering microbial nutrition, growth conditions, enzymology, metabolism, antimicrobial control, drug mechanisms, resistance, epidemiology, and infection terminology for Exam 2 preparation.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Autotroph
Organism that uses inorganic CO₂ as its carbon source.
Heterotroph
Organism that must obtain carbon in organic form.
Phototroph
Microbe that gains energy from light by photosynthesis.
Chemotroph
Microbe that gains energy from chemical compounds.
Photoautotroph
Uses light for energy and CO₂ for carbon.
Chemoautotroph
Uses inorganic chemicals for energy and CO₂ for carbon.
Photoheterotroph
Uses light for energy and organic compounds for carbon.
Chemoheterotroph
Uses organic compounds for both energy and carbon.
Psychrophile
Grows best at 0–15 °C; cannot grow above 20 °C.
Mesophile
Optimum growth at 20–40 °C; includes most human pathogens.
Thermophile
Grows optimally at 45–80 °C; lives in hot soil/water.
Barophile
Requires very high hydrostatic pressure for growth.
Halophile
Requires high salt concentrations (9–25 % NaCl) for growth.
Enzyme
Biological catalyst that lowers activation energy and speeds reactions.
Activation Energy
Energy barrier that must be overcome for a reaction to proceed.
Substrate
Reactant molecule on which an enzyme acts.
Apoenzyme
Protein portion of an enzyme without its cofactor.
Cofactor
Non-protein ion (e.g., Fe, Cu, Co) that activates or assists an enzyme.
Coenzyme
Organic cofactor (often vitamin-derived) that transfers groups between substrates.
Holoenzyme
Complete, active enzyme composed of apoenzyme plus cofactors/coenzymes.
Lag Phase
Adjustment period of a culture; little or no cell division.
Exponential (Log) Phase
Rapid, geometric increase in cell numbers under favorable conditions.
Stationary Phase
Rates of cell growth and death are equal; nutrients become limited.
Death Phase
Cells die exponentially as limiting factors intensify.
Competitive Inhibition
Look-alike molecule occupies enzyme’s active site, blocking substrate.
Noncompetitive Inhibition
Regulatory molecule binds to a site other than the active site and inactivates the enzyme.
NADH
Primary electron carrier generated mainly in the Krebs cycle (6 per glucose).
ATP
Adenosine triphosphate—cellular energy currency for storage and use.
Glycolysis
Anaerobic breakdown of glucose to 2 pyruvate, yielding 2 ATP and 2 NADH.
Krebs Cycle
Cyclic pathway that oxidizes acetyl-CoA, generating 2 ATP, 6 NADH, 2 FADH₂ per glucose.
Electron Transport Chain
Series of membrane carriers that generate ~34 ATP using NADH/FADH₂ electrons.
Aerobic Respiration
Glycolysis + Krebs + ETC using O₂; yields 36–38 ATP, CO₂, H₂O.
Anaerobic Respiration
Glycolysis + Krebs + ETC with non-oxygen final acceptor; 2–36 ATP.
Fermentation
Glycolysis only; converts pyruvate to acids/alcohols; regenerates NAD⁺; yields 2 ATP.
Aerobe
Organism able to use oxygen in metabolism.
Obligate Aerobe
Cannot grow without oxygen.
Facultative Anaerobe
Uses O₂ when present; can switch to anaerobic metabolism when absent.
Microaerophile
Requires small amounts of oxygen; does not grow at atmospheric levels.
Anaerobe
Cannot use oxygen for metabolism.
Obligate Anaerobe
Dies in the presence of oxygen.
Aerotolerant Anaerobe
Does not use O₂ but can survive limited exposure.
Obligate Acidophile
Requires an acidic environment to grow.
Alkalinophile
Thrives in environments with high alkaline pH.
Disinfection
Physical or chemical destruction of vegetative pathogens on inanimate objects; not endospores.
Sterilization
Complete removal/destruction of all microbial life on inanimate objects.
Antisepsis / Degermation
Disinfection of living tissue to reduce pathogen numbers.
Decontamination / Sanitization
Mechanical removal of microbes to safe levels on animate or inanimate objects.
Bactericide
Agent that kills bacteria (not necessarily endospores).
Bacteriostatic
Agent that inhibits bacterial reproduction without killing.
Pasteurization
Heat treatment that removes pathogens (e.g., Salmonella, Mycobacterium) while sparing many harmless microbes.
Autoclave
Steam under pressure (121 °C, 15 psi) device used for moist-heat sterilization.
Halogens
Chlorine, iodine, fluorine, bromine—common, broad-spectrum antimicrobial chemicals.
Sulfonamides
Drugs that block folic-acid synthesis by competing with PABA for dihydropteroate synthase.
PABA
Para-aminobenzoic acid; normal substrate for folic acid pathway blocked by sulfa drugs.
Narrow-Spectrum Drug
Antimicrobial effective against a specific group; e.g., isoniazid.
Broad-Spectrum Drug
Antimicrobial effective against multiple groups; e.g., tetracyclines.
Beta-lactam Drugs
Penicillins/cephalosporins that inhibit cell-wall peptidoglycan synthesis.
Spontaneous Mutation
Random genetic change that can confer drug resistance.
Horizontal Gene Transfer
Acquisition of resistance genes via conjugation, transformation, or transduction.
Plasmid
Small circular DNA that often carries antibiotic resistance factors.
Transposon
Mobile DNA segment that can move resistance genes within or between genomes.
Fomite
Inanimate object that transmits pathogens (e.g., doorknob, phone).
Axenic
State of being free of all living microorganisms; sterile.
Lipopolysaccharide (LPS)
Outer-membrane molecule of Gram-negative bacteria that acts as endotoxin.
Endotoxin
Toxic LPS shed by Gram-negative bacteria causing fever and inflammation.
Incubation Period
Time from contact with pathogen to first symptoms.
Prodromal Stage
Early, vague symptoms signaling onset of illness.
Acute Phase
Height of infection; pathogen multiplies at high levels and causes peak symptoms.
Convalescent Stage
Symptoms decline as host recovers.
Continuation Phase
Pathogen or symptoms persist for months or years in some diseases.
Localized Infection
Microbe confined to a specific tissue or site.
Systemic Infection
Infection spreads to several sites via bloodstream or fluids.
Focal Infection
Begins locally then seeds infection in other tissues.
Mixed Infection
Simultaneous infection by several different microbes.
Primary Infection
First or initial infection in a host.
Secondary Infection
New infection occurring during or after treatment of a primary infection.
Acute Infection
Rapid onset, short duration illness.
Chronic Infection
Long-lasting or persistent infection.
Epidemiology
Study of disease frequency, distribution, and determinants in populations.
Endemic Disease
Disease with steady, predictable frequency in a locale.
Sporadic Disease
Disease that appears irregularly and infrequently.
Epidemic Disease
Sudden, higher-than-expected outbreak in a region.
Pandemic Disease
Epidemic that spreads across continents.
BSL-1
Handles non-pathogenic microbes; minimal biosafety requirements.
BSL-2
Handles moderate-risk agents; lab coats, biosafety cabinets required.
BSL-3
Handles airborne, serious pathogens; controlled access, negative pressure labs.
BSL-4
Handles life-threatening agents with no treatment; full-body suits, isolated facility.
Cell Wall Inhibitors
Drugs such as penicillins and vancomycin that block peptidoglycan synthesis.
Cell Membrane Inhibitors
Drugs such as polymyxins and daptomycin that disrupt membrane integrity.
Folic Acid Synthesis Inhibitors
Sulfonamides and trimethoprim that block tetrahydrofolate formation.
Protein Synthesis Inhibitors
Agents like erythromycin and clindamycin that bind ribosomal subunits.
DNA/RNA Inhibitors
Rifampin and quinolones that obstruct transcription or DNA gyrase.
Penicillin
Prototype beta-lactam antibiotic targeting cell-wall cross-linking enzymes.
Vancomycin
Glycopeptide antibiotic that blocks peptidoglycan elongation; used for MRSA.
Polymyxin
Cyclic peptide that binds LPS and disrupts Gram-negative membranes.
Daptomycin
Lipopeptide that depolarizes Gram-positive cell membranes.
Trimethoprim
Synergistic with sulfonamides; blocks dihydrofolate reductase in folate pathway.
Erythromycin
Macrolide that blocks the 50S ribosomal translocation step.
Clindamycin
Lincosamide that inhibits peptide bond formation on the 50S subunit.
Rifampin
Blocks bacterial RNA polymerase; treats tuberculosis.